SCHEMBL6646

SCHEMBL6646

CCOC(=O)C1(c2ccc(-c3ccc(-c4onc(C)c4C[C@@H](O)O[C@H](C)c4ccccc4)cc3)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 6/20 0.52
ABCC3 O15438 1/20 0.52
ABCC4 O15439 1/20 0.52
ABCB11 O95342 1/20 0.52
CYP2C8 P10632 1/20 0.52
CYP2C9 P11712 1/20 0.52
ABCB4 P21439 1/20 0.52
ABCC2 Q92887 1/20 0.52
SLCO1B3 Q9NPD5 1/20 0.52
SLCO1B1 Q9Y6L6 1/20 0.52
KCNA3 P22001 1/20 0.41
OPRM1 P35372 7/20 0.40
OPRD1 P41143 5/20 0.39
OPRK1 P41145 5/20 0.39
LPAR3 Q9UBY5 2/20 0.39
SLC22A1 O15245 1/20 0.39
SLC6A4 P31645 1/20 0.39
ADRA1A P35348 1/20 0.39
KCNH2 Q12809 1/20 0.39
HRH1 P35367 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1621 0.86 LPAR1 (0.48) LPAR1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL1246 0.85 ABCC3 (0.43) LPAR1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL1787 0.85 ABCC3 (0.43) LPAR1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL18597869 0.85 LPAR1 (0.53) LPAR1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL1689 0.84 KCNA3 (0.42) LPAR1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL2058 0.84 KCNA3 (0.42) LPAR1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL1841 0.83 ABCC3 (0.48) LPAR1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL6595 0.82 ABCC3 (0.43) LPAR1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL1893 0.82 ABCC3 (0.45) LPAR1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL1687 0.82 LPAR1 (0.53) LPAR1ABCC3ABCC4ABCB11CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed